TrialInternational journal of clinical practice2011

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.

R Pratley et al.PubMed ↗Full text ↗Publisher ↗

A later paper about NCT00700817. The trial’s primary report, PMID 20417856, speaks for it on the map; the numbers here are shown and do not vote.

No numbers read from the abstract.